FindTrial
Sign In

Construction of high risk subtype model of pulmonary nodule micropapillary

Integrated Traditional Chinese and Western Medicine Clinical Medical Innovation Center for Pulmonary Nodules

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ITMCTR
Registry ID
ITMCTR2025001334
Enrollment
Unknown
Registered
2025-07-03
Start date
2024-07-08
Completion date
Unknown
Last updated
2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pulmonary nodule

Interventions

malignant pulmonary nodules group:none
benign pulmonary nodules group:none

Sponsors

Department of Respiratory and Critical Care Medicine Jiangsu Provincial Hospital of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1) Patients aged 18-75 years;2) Each patient's chest CT demonstrates =1 pulmonary nodule(s) measuring =2 cm in size with pure ground-glass component accounting for =50% of the nodule(s);3) Postoperative patients have confirmed pathological diagnosis indicative of lung adenocarcinoma or benign lesions;4) No history of other malignant diseases or antitumor treatments within the past five years.

Exclusion criteria

Exclusion criteria: none

Design outcomes

Primary

MeasureTime frame
Pathological typing detection;—

Secondary

MeasureTime frame
Fragmentary genomics testing;Imaging omics features of pulmonary nodules;Traditional Chinese Medicine Symptom information;Traditional Chinese Medicine Constitution Information;—

Countries

China

Contacts

Public ContactXianmei Zhou

Department of Respiratory and Critical Care Medicine Jiangsu Provincial Hospital of Traditional Chinese Medicine

zhouxianmeijs@aliyun.com025 8661 7141

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026